Sevelamer Hydrochloride Tablet
Product Images NDC 70748-173

4 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 70748-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 01)

01 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 01)
Chemical structure diagram of Sevelamer hydrochloride polymer. The figure highlights primary amine groups, protonated amines, crosslinking groups, and the extended polymer network, with annotations for variables a, b, c, n, and m indicating structural details.*
FDA Label Image

02 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 02)

02 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 02)
A line graph showing the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL) for Sevelamer hydrochloride compared to an active control. The x-axis represents the reduction in serum phosphorus, with labels indicating worsened increase and improved reduction. The y-axis shows the percentage of patients with reduction greater than or equal to the given value.*
FDA Label Image

03 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 03)

03 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 03)
A line chart showing phosphorus change from baseline over a 52-week study period. The x-axis represents study weeks from 0 to 52, and the y-axis represents phosphorus change from baseline, ranging from -5 to 2. Two lines compare Sevelamer Hydrochloride treatment and an active control, illustrating changes in phosphorus levels over time.*
FDA Label Image

07 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 04)

07 (Cc130cfa F3e5 460d 92a8 69cc0f958dd2 04)
Label for Sevelamer Hydrochloride Tablets 800 mg, oral tablets, from Lupin Pharmaceuticals, Inc. The label includes the NDC 70748-173-26, indicates 180 tablets per container, and lists storage instructions, manufacturer information, and a barcode. The product is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.